相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Monoclonal Anti-Claudin 1 Antibodies Prevent Hepatitis C Virus Infection of Primary Human Hepatocytes
Isabel Fofana et al.
GASTROENTEROLOGY (2010)
Inhibition of Hepatitis C Virus Infection by Anti-Claudin-1 Antibodies Is Mediated by Neutralization of E2-CD81-Claudin-1 Associations
Sophie E. Krieger et al.
HEPATOLOGY (2010)
Claudin Association with CD81 Defines Hepatitis C Virus Entry
Helen J. Harris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation
Samira Fafi-Kremer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Practical evaluation of a mouse with chimeric human liver model for hepatitis C virus infection using an NS3-4A protease inhibitor
Naohiro Kamiya et al.
JOURNAL OF GENERAL VIROLOGY (2010)
A chemical and phosphoproteomic characterization of dasatinib action in lung cancer
Jiannong Li et al.
NATURE CHEMICAL BIOLOGY (2010)
Control of tight junctional sealing: roles of epidermal growth factor and prostaglandin E2
D. Flores-Benitez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors
Cecilia Frecha et al.
BLOOD (2009)
EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt
Hui Miao et al.
CANCER CELL (2009)
The Epidermal Growth Factor Receptor Ligands at a Glance
Marlon R. Schneider et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells
Jeroen Witteveldt et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Treatment failure in hepatitis C: Mechanisms of non-response
Andrew W. Tai et al.
JOURNAL OF HEPATOLOGY (2009)
Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice
Nobuhiko Hiraga et al.
JOURNAL OF HEPATOLOGY (2009)
Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells
Christopher J. Mee et al.
JOURNAL OF VIROLOGY (2009)
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
Alexander Ploss et al.
NATURE (2009)
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
Christophe Hezode et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Receptor Complementation and Mutagenesis Reveal SR-BI as an Essential HCV Entry Factor and Functionally Imply Its Intra- and Extra-Cellular Domains
Marlene Dreux et al.
PLOS PATHOGENS (2009)
Host neutralizing responses and pathogenesis of hepatitis C virus infection
Mirjam B. Zeisel et al.
HEPATOLOGY (2008)
CD81 and claudin 1 coreceptor association: Role in hepatitis C virus entry
Helen J. Harris et al.
JOURNAL OF VIROLOGY (2008)
Modeling oncogene addiction using RNA interference
S. Michael Rothenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Eph, a Protein Family Coming of Age: More Confusion, Insight, or Complexity?
Martin Lackmann et al.
SCIENCE SIGNALING (2008)
Hepatitis C virus entry
Thomas von Hahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Isolation and characterization of broadly neutralizing human monoclonal antibodies to the E1 glycoprotein of hepatitis C virus
Jean-Christophe Meunier et al.
JOURNAL OF VIROLOGY (2008)
Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies
Jennifer M. Timpe et al.
HEPATOLOGY (2008)
Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81
Mirjam B. Zeisel et al.
HEPATOLOGY (2007)
Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus
Dirnitri Lavillette et al.
JOURNAL OF VIROLOGY (2007)
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
Matthew J. Evans et al.
NATURE (2007)
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C
Jan M. Pestka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction
Heidi Barth et al.
JOURNAL OF VIROLOGY (2006)
High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI
Marlene Dreux et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Hepatitis C virus entry depends on clathrin-mediated endocytosis
Emmanuelle Blanchard et al.
JOURNAL OF VIROLOGY (2006)
Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses
George Koutsoudakis et al.
JOURNAL OF VIROLOGY (2006)
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras
Thomas Pietschmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Erlotinib in previously treated non-small-cell lung cancer
FA Shepherd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera
P Meuleman et al.
HEPATOLOGY (2005)
Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus
D Lavillette et al.
HEPATOLOGY (2005)
Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells
AB Singh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models
B Higgins et al.
ANTI-CANCER DRUGS (2004)
Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon
T Kato et al.
GASTROENTEROLOGY (2003)
Pharmacokinetics and pharmacodynamics: Maximizing the clinical potential of erlotinib (Tarceva)
M Hidalgo et al.
SEMINARS IN ONCOLOGY (2003)
Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes
B Bartosch et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth
DF McCole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
E Scarselli et al.
EMBO JOURNAL (2002)
Ligand-induced, receptor-mediated dimerization and activation of EGF receptor
J Schlessinger
CELL (2002)
Negative regulation of EphA2 receptor by Cbl
YJ Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
分享论文
